|
ROCK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.965600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.389800E-02 |
| Normal-vs-Stage2 |
1.878250E-02 |
| Normal-vs-Stage3 |
1.86280000002981E-06 |
| Normal-vs-Stage4 |
3.60090000040003E-08 |
| Stage1-vs-Stage2 |
2.153000E-01 |
| Stage1-vs-Stage3 |
8.203200E-04 |
| Stage1-vs-Stage4 |
3.10000000003363E-06 |
| Stage2-vs-Stage3 |
3.514800E-01 |
| Stage2-vs-Stage4 |
9.455500E-02 |
| Stage3-vs-Stage4 |
2.412200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.047200E-04 |
| Normal-vs-AfricanAmerican |
2.14490000000067E-05 |
| Normal-vs-Asian |
6.616800E-01 |
| Caucasian-vs-AfricanAmerican |
3.605900E-02 |
| Caucasian-vs-Asian |
4.355600E-01 |
| AfricanAmerican-vs-Asian |
1.239580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.38699999999859E-05 |
| Normal-vs-Female |
8.002200E-03 |
| Male-vs-Female |
1.274420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.285730E-02 |
| Normal-vs-Age(41-60Yrs) |
1.033980E-02 |
| Normal-vs-Age(61-80Yrs) |
5.54799999999966E-05 |
| Normal-vs-Age(81-100Yrs) |
1.337820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.631400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.738200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.760600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.376000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.365220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.514200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.454800E-01 |
| Normal-vs-Grade 2 |
6.492100E-02 |
| Normal-vs-Grade 3 |
4.58579999973452E-07 |
| Normal-vs-Grade 4 |
2.07739999646961E-08 |
| Grade 1-vs-Grade 2 |
1.432990E-01 |
| Grade 1-vs-Grade 3 |
9.579200E-04 |
| Grade 1-vs-Grade 4 |
8.16230000000306E-05 |
| Grade 2-vs-Grade 3 |
1.598870E-04 |
| Grade 2-vs-Grade 4 |
1.32170000000098E-06 |
| Grade 3-vs-Grade 4 |
6.200500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.154200E-01 |
| Normal-vs-ccB subtype |
2.00879999999737E-05 |
| ccA subtype-vs-ccB subtype |
5.57740000000084E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.183800E-04 |
| Normal-vs-N1 |
2.542500E-03 |
| N0-vs-N1 |
2.175000E-01 |
|
|
